Share-based Payment Arrangement, Expense in USD of Applied Therapeutics, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Applied Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q1 2018 to Q3 2025.
  • Applied Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1.14M, a 45.4% decline year-over-year.
  • Applied Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $13.9M, a 74.5% increase year-over-year.
  • Applied Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $15.6M, a 112% increase from 2023.
  • Applied Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.36M, a 23.4% decline from 2022.
  • Applied Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.6M, a 14.1% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Applied Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $13.9M $1.14M -$950K -45.4% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $14.9M $2.1M +$210K +11.1% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $14.7M $1.49M -$892K -37.5% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $15.6M $9.21M +$7.58M +466% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 $7.99M $2.09M +$255K +13.9% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 $7.73M $1.89M +$47K +2.55% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 $7.68M $2.38M +$324K +15.8% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $7.36M $1.63M -$813K -33.3% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 $8.17M $1.84M -$1.02M -35.7% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $9.19M $1.84M -$388K -17.4% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $9.58M $2.06M -$22K -1.06% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $9.6M $2.44M -$410K -14.4% 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 $10M $2.86M +$211K +7.98% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $9.8M $2.23M -$471K -17.4% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $10.3M $2.08M -$904K -30.3% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $11.2M $2.85M +$130K +4.78% 01 Oct 2021 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 $11M $2.65M +$242K +10.1% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $10.8M $2.7M +$1.13M +71.8% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 $9.68M $2.98M +$1.65M +124% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $8.03M $2.72M +$1.37M +102% 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 $6.66M $2.4M +$1.18M +97% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $5.47M $1.57M -$1.71M -52% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $7.18M $1.33M +$1.01M +310% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q4 2019 $6.17M $1.35M +$1.26M +1365% 01 Oct 2019 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 $4.92M $1.22M +$1.14M +1464% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 $3.77M $3.28M +$3.2M +4213% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 $571K $325K +$299K +1150% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 $272K $92K 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020
Q3 2018 $78K 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 $76K 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019
Q1 2018 $26K 01 Jan 2018 31 Mar 2018 10-Q 21 Jun 2019

Applied Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $15.6M +$8.21M +112% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 $7.36M -$2.24M -23.4% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 $9.6M -$1.57M -14.1% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024
2021 $11.2M +$3.15M +39.3% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023
2020 $8.03M +$1.86M +30.1% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022
2019 $6.17M +$5.9M +2169% 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
2018 $272K 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.